Team:HK HCY LFC/Demonstrate
Home
Team
Team Members Collaborations
Project
Description Design Experiments Notebook InterLab Model Results Demonstration Improvement Attributions
Parts Overview Safety
Human Practices
Human Practices Education & Engagement
Judging Form
Team:HK HCY LFC - 20118.igem.org
Comparison between the conventional diagnostic  methods and our new approach for the diagnosis of SCA
References
[1] Edyta Koscianska and Wlodzimierz J Krzyzosiak, Current understanding of the role of microRNAs in spinocerebellar ataxias, Koscianska and Krzyzosiak Cerebellum & Ataxias 2014, 1:7
[2] Margherita Grasso, Paola Piscopo, Alessio Crestini, Annamaria Confaloni, Michela A. Denti, Circulating microRNAs in Neurodegenerative Diseases, Nov 2015
[3] David Yu Zhang and Georg Seelig, Dynamic DNA nanotechnology using strand-displacement reactions, Jan 2011, DOI:10.1038/NCHEM.957
[4]What is the cost of genetic testing, and how long does it take to get the results?, U.S. National Library of Medicine, https://ghr.nlm.nih.gov/primer/testing/costresults
[5] Ashton Powell,PhD, Subhashini Chandrasekharan,PhD, and Robert Cook-Deegan,MD, Spinocerebellar Ataxia:Patient and Health Professional Perspectives on Whether and How Patents Affect Access      to Clinical Genetic Testing, Genet Med.2010 Apr; 12(4 Suppl):S83-S110
[6] Kewlal K. Jain, Applications of Nanobiotechnology in Clinical Diagnostics, Clinical Chemistry;Nov 2007;53,11
[7] Prof. LW Chu, Challenges in the diagnosis and management of dementia in Hong Kong, Hong Kong Med J 2017 Jun;23(3):218-9
[8] What are the risks and limitations of genetic testing?, U.S. National Library of Medicine, https://ghr.nlm.nih.gov/primer/testing/riskslimitations
Â© IGEM HCYxLFC 2018 - All Rights Reserved.
